methamphetamine and n-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide

methamphetamine has been researched along with n-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koob, GF; Newman, AH; Orio, L; Pulvirenti, L; Wee, S	1

Other Studies

1 other study(ies) available for methamphetamine and n-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide

Article	Year
The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addiction biology, 2010, Volume: 15, Issue:3 Topics: Amphetamine-Related Disorders; Animals; Benzamides; Central Nervous System Stimulants; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Infusions, Intravenous; Male; Methamphetamine; Motivation; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D3; Reinforcement Schedule; Self Administration	2010

Article

Year

The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Addiction biology, 2010, Volume: 15, Issue:3

Topics: Amphetamine-Related Disorders; Animals; Benzamides; Central Nervous System Stimulants; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Infusions, Intravenous; Male; Methamphetamine; Motivation; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D3; Reinforcement Schedule; Self Administration

2010